This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stark, M. Articles by Lundeberg, J. Search for Related Content PubMed PubMed Citation Articles by Stark, M. Articles by Lundeberg, J.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, Apr 1996, 778-784, Vol 34, No. 4
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

Immunomagnetic separation and solid-phase detection of Bordetella pertussis

M Stark, E Reizenstein, M Uhlen and J Lundeberg
Department of Biochemistry, KTH, Royal Institute of Technology, Stockholm, Sweden.

In the present study, novel solid-phase methods were used for both sample preparation and PCR detection of Bordetella pertussis. The sample preparation was performed by immunomagnetic separation with paramagnetic beads coated with polyclonal antibodies directed toward the surface antigens of the bacteria. The precoated immunobeads were directly used on nasopharyngeal aspirates to capture the bacteria on the solid support and were subsequently transferred to the PCR tube with no further manipulations. The region encompassing the pertussis toxin promoter was analyzed to allow direct discrimination between the three major Bordetella species (B. pertussis, B. parapertussis, and B. bronchiseptica). The resulting amplicons were captured on a second magnetic solid phase, allowing detection and restriction analysis of the target sequence. A colorimetric detection system based on a DNA binding fusion protein enabled the use of standardized enzyme-linked immunosorbent format tests both for the detection of Bordetella spp. and for species evaluation. When the optimized system was evaluated on 55 clinical aspirate samples, 21 of 22 (95%) culture-positive samples were positive by the system that we developed. In addition, two samples were positive by the PCR-based assay, while the culture assay was negative. The implications of these results are discussed.

This article has been cited by other articles:

• Morata, P., Queipo-Ortuno, M. I., Reguera, J. M., Garcia-Ordonez, M. A., Cardenas, A., Colmenero, J. D. (2003). Development and Evaluation of a PCR-Enzyme-Linked Immunosorbent Assay for Diagnosis of Human Brucellosis. J. Clin. Microbiol. 41: 144-148 [Abstract] [Full Text]  
• Nygren, M., Reizenstein, E., Ronaghi, M., Lundeberg, J. (2000). Polymorphism in the Pertussis Toxin Promoter Region Affecting the DNA-Based Diagnosis of Bordetella Infection. J. Clin. Microbiol. 38: 55-60 [Abstract] [Full Text]  
• O'Meara, D., Yun, Z., Sönnerborg, A., Lundeberg, J. (1998). Cooperative Oligonucleotides Mediating Direct Capture of Hepatitis C Virus RNA from Serum. J. Clin. Microbiol. 36: 2454-2459 [Abstract] [Full Text]